BCRX vs MPWR · rev $374.7M vs P/E 112, rev $1.78B
BioCryst Pharmaceuticals Inc (BCRX) versus Monolithic Power Systems Inc (MPWR) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Monolithic Power Systems Inc (MPWR) is a semiconductors company listed on US.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported MPWR revenue for 2026-06-30 was $1.78B. Net income was $450.5M. MPWR currently screens at market cap $77.49B and trailing P/E 112.3.
BCRX currently screens at market cap $1.83B. MPWR currently screens at market cap $77.49B and trailing P/E 112.3.
Not investment advice. Open the BCRX and MPWR stock pages for the full models.
Not investment advice.